While the one-year mortality reduction for SupraMR vs MR reached borderline significance (RR 0.61, 95 % CI 0.38–0.99, P = .05), the HR comparison did not reach statistical significance (HR 0.63, 95 % CI 0.36–1.12, P = .09).
← all excerpts
Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis.
3
0.0500
0.0900
The sentences
While the one-year mortality reduction for SupraMR vs MR reached borderline significance (RR 0.61, 95 % CI 0.38–0.99, P = .05), the HR comparison did not reach statistical significance (HR 0.63, 95 % CI 0.36–1.12, P = .09).
The pooled HR was 0.69 (95 % CI, 0.63–0.74; P < .00001), demonstrating a highly significant 31 % reduction in mortality hazard for patients undergoing MR ( Fig. 6 ).